Researchers Identify “Druggable” Signaling Pathway that Stimulates Lung Tissue Repair
Findings from a CHOP/Penn Medicine study could lead to treatment for patients with lung disease, including acute respiratory distress syndrome due to COVID-19
Published on in CHOP News